BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2438880)

  • 1. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
    Göransson A
    Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
    Göransson A
    Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
    Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
    Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis.
    Greaves MW
    Int J Clin Pharmacol Res; 1986; 6(4):315-6. PubMed ID: 2428761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM; Kolari PJ; Mustakallio KK
    Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
    Göring HD; Voss M
    Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-contact treatment at home with Micanol.
    Volden G; Björnberg A; Tegner E; Pedersen NB; Arlés UB; Agren S; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1992; 172():20-2. PubMed ID: 1585757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient treatment with short-contact dithranol. The impact of frequent concentration adjustments.
    de Mare S; Calis N; den Hartog G; van de Kerkhof PC
    Acta Derm Venereol; 1989; 69(5):449-51. PubMed ID: 2572119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Christensen OB; Holst R; Hradil E; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-month dermal toxicity test with dithranol and butantrone in miniature swine.
    Männistö PT; Hanhijärvi H; Kosma VM; Collan Y
    Contact Dermatitis; 1986 Jul; 15(1):1-9. PubMed ID: 2944694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the frequency of short contact dithranol treatment.
    Prins M; Swinkels OQ; Van de Kerkhof PC; Van der Valk PG
    Eur J Dermatol; 2001; 11(3):214-8. PubMed ID: 11358727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis.
    Thune P; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1992; 172():28-9. PubMed ID: 1585760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Minute therapy" of psoriasis with dithranol and its modifications. A critical evaluation based on 315 patients].
    Runne U; Kunze J
    Hautarzt; 1985 Jan; 36(1):40-6. PubMed ID: 3972578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
    Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of active chronic psoriasis: a comparison of the effectiveness of a preparation containing 0.1% dithranol and 17% urea in a cream base and 0.1% dithranol in Lassar's past B.P.C.
    Portnoy B; Beck MH
    Acta Derm Venereol; 1981; 61(5):459-61. PubMed ID: 6172945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.